For recommended dosing adjustments in patients with renal impairment see    PRECAUTIONS section.
Chemotherapy courses are repeated at 3- to 4-week intervals after adequate recovery from any toxicity.
In small cell lung cancer, the recommended dose of VePesid (etoposide)  Capsules is two    times the IV dose rounded to the nearest 50 mg (i.e., two times 35 mg/m2/day    for 4 days to 50 mg/m2/day for 5 days).
The dosage should be modified to take into account the myelosuppressive effects of other drugs in the combination or the effects of prior x-ray therapy or chemotherapy which may have compromised bone marrow reserve.
To minimize the risk of dermal exposure, always wear impervious gloves when handling blisterpacks of individually labeled blisters containing VePesid (etoposide)  capsules. This includes all handling activities in clinical settings, pharmacies, storerooms, and home healthcare settings, including during unpacking and inspection, transport within a facility, and dose preparation and administration.
VePesid (etoposide)  Capsules must be stored under refrigeration 2째 - 8째  C (36째 - 46째  F). The capsules are stable for 24 months under such refrigeration conditions.
Procedures for proper handling and disposal of anticancer drugs should    be considered. Several guidelines on this subject have been published.1-8    There is no general agreement that all of the procedures recommended in the    guidelines are necessary or appropriate.
